Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes

被引：0
|
作者：
Xiaohao Ruan
Da Huang
Jingyi Huang
James Hok-Leung Tsu
Rong Na
机构：
[1] Shanghai Jiao Tong University School of Medicine,Department of Urology, Ruijin Hospital
[2] The University of Hong Kong,Division of Urology, Department of Surgery, Queen Mary Hospital
来源：
Journal of Translational Medicine | / 21卷
关键词：
Benign prostatic hyperplasia; Germline mutation; Polygenic risk score; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Genetic polymorphisms and prostate cancer risk
    Gsur, A
    Feik, E
    Madersbacher, S
    WORLD JOURNAL OF UROLOGY, 2004, 21 (06) : 414 - 423
  • [42] Genetic polymorphisms and prostate cancer risk
    Andrea Gsur
    Elisabeth Feik
    Stephan Madersbacher
    World Journal of Urology, 2004, 21 : 414 - 423
  • [43] Genetic counseling for prostate cancer risk
    Nieder, AM
    Taneja, SS
    Zeegers, MPA
    Ostrer, H
    CLINICAL GENETICS, 2003, 63 (03) : 169 - 176
  • [44] Circadian genes and risk of prostate cancer in the prostate cancer prevention trial
    Chu, Lisa W.
    Till, Cathee
    Yang, Baiyu
    Tangen, Catherine M.
    Goodman, Phyllis J.
    Yu, Kai
    Zhu, Yong
    Han, Summer
    Hoque, Ashraful M.
    Ambrosone, Christine
    Thompson, Ian
    Leach, Robin
    Hsing, Ann W.
    MOLECULAR CARCINOGENESIS, 2018, 57 (03) : 462 - 466
  • [45] Joint associations between established genetic susceptibility loci, pesticide exposures, and risk of prostate cancer
    Hurwitz, Lauren M.
    Freeman, Laura E. Beane
    Andreotti, Gabriella
    Hofmann, Jonathan N.
    Parks, Christine G.
    Sandler, Dale P.
    Lubin, Jay H.
    Liu, Jia
    Jones, Kristine
    Berndt, Sonja I.
    Koutros, Stella
    ENVIRONMENTAL RESEARCH, 2023, 237
  • [46] Genetic Susceptibility to Type 2 Diabetes Is Associated with Reduced Prostate Cancer Risk
    Pierce, Brandon L.
    Ahsan, Habibul
    HUMAN HEREDITY, 2010, 69 (03) : 193 - 201
  • [47] Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors
    Mabey, Brent
    Hughes, Elisha
    Kucera, Matthew
    Simmons, Timothy
    Hullinger, Brooke
    Pederson, Holly J.
    Yehia, Lamis
    Eng, Charis
    Garber, Judy
    Gary, Monique
    Gordon, Ora
    Klemp, Jennifer R.
    Mukherjee, Semanti
    Vijai, Joseph
    Olopade, Olufunmilayo I.
    Pruthi, Sandhya
    Kurian, Allison
    Robson, Mark E.
    Whitworth, Pat W.
    Pal, Tuya
    Ratzel, Sarah
    Wagner, Susanne
    Lanchbury, Jerry S.
    Taber, Katherine Johansen
    Slavin, Thomas P.
    Gutin, Alexander
    Offi, Kenneth
    GENETICS IN MEDICINE, 2024, 26 (07)
  • [48] Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients
    Xu, Jianfeng
    Isaacs, William B.
    Mamawala, Mufaddal
    Shi, Zhuqing
    Landis, Patricia
    Petkewicz, Jacqueline
    Wei, Jun
    Wang, Chi-Hsiung
    Resurreccion, W. Kyle
    Na, Rong
    Bhanji, Yasin
    Novakovic, Kristian
    Walsh, Patrick C.
    Zheng, S. Lilly
    Helfand, Brian T.
    Pavlovich, Christian P.
    PROSTATE, 2021, 81 (10): : 703 - 709
  • [49] Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history
    Hassanin, Emadeldin
    May, Patrick
    Aldisi, Rana
    Spier, Isabel
    Forstner, Andreas J.
    Nothen, Markus M.
    Aretz, Stefan
    Krawitz, Peter
    Bobbili, Dheeraj Reddy
    Maj, Carlo
    GENETICS IN MEDICINE, 2022, 24 (03) : 576 - 585
  • [50] Hereditary cancer risk assessment and genetic testing in the community urology practice setting
    Shore, Neal D.
    Lenz, Lauren
    Cogan, Elizabeth S.
    Iliev, Diana
    Spencer, Lizzie
    Flake, Darl D.
    Meek, Stephanie
    Davis, Thaylon
    Copeland, Karen
    Finch, Robert
    Schiff, William
    Korman, Howard
    Rao, Manoj
    Belkoff, Laurence
    Jalkut, Mark
    Mariados, Neil
    D'Anna, Richard
    Mehlhaff, Bryan
    Slavin, Thomas P.
    Cohen, Todd D.
    PROSTATE, 2022, 82 (07): : 850 - 857
12345